XML 30 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in and reports as a single reportable segment, focused on the development of innovative ophthalmic pharmaceutical products.

Our Chief Operating Decision Maker "CODM" is our President and Chief Executive Officer. The CODM does not evaluate profitability nor evaluate performance or allocate resources below the level of the consolidated Company. The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM reviews operating expenses and net (loss) income presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. These metrics serve as benchmarks to evaluate the business, measure performance, identify trends, prepare financial projections, and make strategic decisions. The CODM does not evaluate performance or allocate resources based on segment assets data; therefore, total segment assets are not presented. As part of the adoption of ASU 2023-07, the comparative prior period segment information has been disclosed herein to align with the current period’s presentation.

The following table presents the revenue, significant expenses, and net (loss) income for the Company’s single reportable segment:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Total Revenue$— $— $— $16,020,000 
Less: Significant and Other Segment Expenses
General and Administrative1,443,827 1,380,997 4,287,075 4,215,411 
Research and Development
KIO-10111,223 8,525 18,017 21,609 
KIO-1041255,085 611,722 532,106 637,619 
KIO-201— — — 30,875 
KIO-3012,057,678 743,842 6,285,162 2,850,958 
KIO-301 Collaboration Credit(1,658,248)(867,760)(5,310,288)(2,200,298)
Unallocated R&D Expenses2405,905 820,902 1,016,981 2,376,807 
In-Process R&D Impairment— 2,008,000 — 2,008,000 
Change in Fair Value of Contingent Consideration(1,721,033)(1,103,991)(1,308,067)(995,951)
Interest Income, Net(201,822)(248,840)(703,692)(813,989)
Other Segment Expenses323,708 59,929 133,517 70,724 
Income Tax Benefit(643,129)— (632,179)— 
Net (Loss) Income$26,806 $(3,413,326)$(4,318,633)$7,818,235